# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-220669
Filing Date
2018-07-18
Accepted
2018-07-18 17:01:10
Documents
19
Period of Report
2018-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d610765d8k.htm | 8-K | 24517
2 | EX-1.1 | d610765dex11.htm | EX-1.1 | 171344
3 | EX-10.1 | d610765dex101.htm | EX-10.1 | 297491
4 | EX-10.2 | d610765dex102.htm | EX-10.2 | 105644
5 | EX-10.3 | d610765dex103.htm | EX-10.3 | 107279
6 | EX-99.1 | d610765dex991.htm | EX-99.1 | 354092
7 | EX-99.2 | d610765dex992.htm | EX-99.2 | 274750
8 | EX-99.3 | d610765dex993.htm | EX-99.3 | 9273
9 | GRAPHIC | g6107651.jpg | GRAPHIC | 19373
10 | GRAPHIC | g610765g00r78.jpg | GRAPHIC | 8216
11 | GRAPHIC | g610765g01n22.jpg | GRAPHIC | 4019
12 | GRAPHIC | g610765g14y84.jpg | GRAPHIC | 138620
13 | GRAPHIC | g610765g17l93.jpg | GRAPHIC | 71786
14 | GRAPHIC | g610765g21e98.jpg | GRAPHIC | 152202
15 | GRAPHIC | g610765g29d13.jpg | GRAPHIC | 16832
16 | GRAPHIC | g610765g43a12.jpg | GRAPHIC | 12236
17 | GRAPHIC | g610765g64g96.jpg | GRAPHIC | 230814
18 | GRAPHIC | g610765g65j68.jpg | GRAPHIC | 21543
19 | GRAPHIC | g610765g73u11.jpg | GRAPHIC | 165192
| Complete submission text file | 0001193125-18-220669.txt |  | 2505712

Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 18958892
SIC: 2834 Pharmaceutical Preparations